No Data
No Data
Fusen Pharmaceutical Company Limited (HKG:1652) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Unfortunately for some shareholders, the Fusen Pharmaceutical Company Limited (HKG:1652) share price has dived 26% in the last thirty days, prolonging recent pain. The drop over the last 30 days ha
Fuson Pharmaceutical (01652) announced the 2023 annual results, shareholders should account for 36.277 million yuan, an increase of 4.83% year-on-year
Fussen Pharmaceutical (01652) announced results for the year ended December 31, 2023, and the group made profits during the period...
FUSEN PHARM: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Fussen Pharmaceutical (01652.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 Fussen Pharmaceutical (01652.HK) announced that the board of directors will meet on March 28, 2024 (Thursday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend (if any).
FUSEN PHARM: NOTICE OF BOARD MEETING
Fuson Pharmaceuticals (01652) estimates annual shareholders' losses of about 35 million to 43 million yuan
Fussen Pharmaceutical (01652) announced that it is expected that the Group's companies for the year ended December 31, 2023 will...
No Data